SEARCH

SEARCH BY CITATION

References

  • Bayer, T.A., Wirths, O., Majtenyi, K., Hartmann, T., Multhaup, G., Beyreuther, K., and Czech, C. 2001. Key factors in Alzheimer's disease: β-Amyloid precursor protein processing, metabolism and intraneuronal transport. Brain Pathol. 11: 111.
  • Bitan, G. and Teplow, D.B. 2004. Rapid photochemical cross-linking—A new tool for studies of metastable, amyloidogenic protein assemblies. Acc. Chem. Res. 37: 357364.
  • Chromy, B.A., Nowak, R.J., Lambert, M.P., Viola, K.L., Chang, L., Velasco, P.T., Jones, B.W., Fernandez, S.J., Lacor, P.N., Horowitz, P., et al. 2003. Self-assembly of Aβ(1-42) into globular neurotoxins. Biochemistry 42: 1274912760.
  • Dahlgren, K.N., Manelli, A.M., Stine, W.B. Jr, Baker, L.K., Krafft, G.A., and LaDu, M.J. 2002. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277: 3204632053.
  • Demuro, A., Mina, E., Kayed, R., Milton, S.C., Parker, I., and Glabe, C.G. 2005. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280: 1729417300.
  • Esler, W.P., Stimson, E.R., Jennings, J.M., Vinters, H.V., Ghilardi, J.R., Lee, J.P., Mantyh, P.W., and Maggio, J.E. 2000. Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry 39: 62886295.
  • Garzon-Rodriguez, W., Sepulveda-Becerra, M., Milton, S., and Glabe, C.G. 1997. Soluble amyloid Aβ-(1-40) exists as a stable dimer at low concentrations. J. Biol. Chem. 272: 2103721044.
  • Harper, J.D., Wong, S.S., Lieber, C.M., and Lansbury, P.T. Jr 1999. Assembly of Aβ amyloid protofibrils: An in vitro model for a possible early event in Alzheimer's disease. Biochemistry 38: 89728980.
  • Hoshi, M., Sato, M., Matsumoto, S., Noguchi, A., Yasutake, K., Yoshida, N., and Sato, K. 2003. Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate τ protein kinase I/glycogen synthase kinase-3β. Proc. Natl. Acad. Sci. 100: 63706375.
  • Hwang, W., Zhang, S., Kamm, R.D., and Karplus, M. 2004. Kinetic control of dimer structure formation in amyloid fibrillogenesis. Proc. Natl. Acad. Sci. 101: 1291612921.
  • Kayed, R., Head, E., Thompson, J.L., McIntire, T.M., Milton, S.C., Cotman, C.W., and Glabe, C.G. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486489.
  • Kim, J. and Lee, M. 2004. Observation of multi-step conformation switching in β-amyloid peptide aggregation by fluorescence resonance energy transfer. Biochem. Biophys. Res. Commun. 316: 393397.
  • Kim, J.R., Muresan, A., Lee, K.Y.C., and Murphy, R.M. 2004. Urea modulation of β-amyloid fibril growth: Experimental studies and kinetic models. Protein Sci. 13: 28882898.
  • Klein, W.L., Krafft, G.A., and Finch, C.E. 2001. Targeting small Aβ oligomers: The solution to an Alzheimer's disease conundrum? Trends Neurosci. 24: 219224.
  • Klunk, W.E., Jacob, R.F., and Mason, R.P. 1999. Quantifying amyloid β-peptide (Aβ) aggregation using the Congo red-Aβ (CR-aβ) spectrophotometric assay. Anal. Biochem. 266: 6676.
  • Kremer, J.J., Pallitto, M.M., Sklansky, D.J., and Murphy, R.M. 2000. Correlation of β-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry 39: 1030910318.
  • Lambert, M.P., Barlow, A.K., Chromy, B.A., Edwards, C., Freed, R., Liosatos, M., Morgan, T.E., Rozovsky, I., Trommer, B., Viola, K.L., et al. 1998. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. 95: 64486453.
  • Lomakin, A., Chung, D.S., Benedek, G.B., Kirschner, D.A., and Teplow, D.B. 1996. On the nucleation and growth of amyloid β-protein fibrils: Detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. 93: 11251129.
  • Lomakin, A., Teplow, D.B., Kirschner, D.A., and Benedek, G.B. 1997. Kinetic theory of fibrillogenesis of amyloid β-protein. Proc. Natl. Acad. Sci. 94: 79427947.
  • McLaurin, J. and Chakrabartty, A. 1997. Characterization of the interactions of Alzheimer β-amyloid peptides with phospholipid membranes. Eur. J. Biochem. 245: 355363.
  • Myers, J.K., Pace, C.N., and Scholtz, J.M. 1995. Denaturant m values and heat capacity changes: Relation to changes in accessible surface areas of protein unfolding. Protein Sci. 4: 21382148.
  • O'Nuallain, B., Shivaprasad, S., Kheterpal, I., and Wetzel, R. 2005. Thermodynamics of Aβ(1-40) amyloid fibril elongation. Biochemistry 44: 1270912718.
  • Pace, C.N. 1990. Measuring and increasing protein stability. Trends Biotechnol. 8: 9398.
  • Pace, C.N., Shirley, B.A., McNutt, M., and Gajiwala, K. 1996. Forces contributing to conformational stability of proteins. FASEB J. 10: 7583.
  • Pallitto, M.M. and Murphy, R.M. 2001. A mathematical model of the kinetics of β-amyloid fibril growth from the denatured state. Biophys. J. 81: 18051822.
  • Pellarin, R. and Caflisch, A. 2006. Interpreting the aggregation kinetics of amyloid peptides. J. Mol. Biol. 360: 882892.
  • Petkova, A.T., Leapman, R.D., Gui, Z., Yau, W.M., Mattson, M., and Tycko, R. 2005. Self propagation, molecular level polymorphism in Alzheimer's β-amyloid fibrils. Science 307: 262265.
  • Petkova, A.T., Yau, W.M., and Tycko, R. 2006. Experimental constraints on the quaternary structure in Alzheimer's β-amyloid fibrils. Biochemistry 45: 498512.
  • Ramírez-Alvarado, M., Merkel, J.S., and Regandagger, L. 2000. A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. Proc. Natl. Acad. Sci. 97: 89798984.
  • Roher, A.E., Baudry, J., Chaney, M.O., Kuo, Y.M., Stine, W.B., and Emmerling, M.R. 2000. Oligomerizaiton and fibril asssembly of the amyloid-β protein. Biochim. Biophys. Acta 1502: 3143.
  • Sabate, R. and Estelrich, J. 2005. Evidence of the existence of micelles in the fibrillogenesis of β-amyloid peptide. J. Phys. Chem. B 109: 1102711032.
  • Shivaprasad, S. and Wetzel, R. 2006. Scanning cystein mutagenesis analysis of Aβ(1-40) amyloid fibrils. J. Biol. Chem. 281: 9931000.
  • Stine, W.B. Jr, Dahlgren, K.N., Krafft, G.A., and LaDu, M.J. 2003. In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278: 1161211622.
  • Terzi, E., Holzemann, G., and Seelig, J. 1997. Interaction of Alzheimer β-amyloid peptide(1-40) with lipid membranes. Biochemistry 36: 1484514852.
  • Tseng, B.P., Esler, W.P., Clish, C.B., Stimson, E.R., Ghilardi, J.R., Vinters, H.V., Mantyh, P.W., Lee, J.P., and Maggio, J.E. 1999. Deposition of monomeric, not oligomeric, Aβ mediates growth of Alzheimer's disease amyloid plaques in human brain preparations. Biochemistry 38: 1042410431.
  • Turner, P.R., O'Connor, K., Tate, W.P., and Abraham, W.C. 2003. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol. 70: 132.
  • Tycko, R. 2006. Characterization of amyloid structures at the molecular level by solid state nuclear magnetic resonance spectroscopy. Methods Enzymol. 413: 103122.
  • Walsh, D.M., Hartley, D.M., Kusumoto, Y., Fezoui, Y., Condron, M.M., Lomakin, A., Benedek, G.B., Selkoe, D.J., and Teplow, D.B. 1999. Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274: 2594525952.
  • Walsh, D.M., Klyubin, I., Fadeeva, J.V., Cullen, W.K., Anwyl, R., Wolfe, M.S., Rowan, M.J., and Selkoe, D.J. 2002. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535539.
  • Wang, S.S., Becerra-Arteaga, A., and Good, T.A. 2002. Development of a novel diffusion-based method to estimate the size of the aggregated Aβ species responsible for neurotoxicity. Biotechnol. Bioeng. 80: 5059.
  • Ward, R.V., Jennings, K.H., Jepras, R., Neville, W., Owen, D.E., Hawkins, J., Christie, G., Davis, J.B., George, A., Karran, E.H., et al. 2000. Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of β-amyloid peptide. Biochem. J. 348: 137144.
  • Westlind-Danielsson, A. and Arnerup, G. 2001. Spontaneous in vitro formation of supramolecular β-amyloid structures, “betaamy balls,” by β-amyloid 1-40 peptide. Biochemistry 40: 1473614743.
  • Whittemore, N.A., Mishra, R., Kheterpal, I., Williams, A., Wetzel, R., and Serpersu, E.H. 2005. Hydrogen deuterium exchange maping of Aβ(1-40) amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy. Biochemistry 44: 44344441.
  • Williams, A., Shivaprasad, S., and Wetzel, R. 2006. Alanine scanning mutagenesis of Aβ(1-40) amyloid fibril stability. J. Mol. Biol. 357: 12831294.
  • Wogulis, M., Wright, S., Cunningham, D., Chilcote, T., Powell, K., and Rydel, R.E. 2005. Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J. Neurosci. 25: 10711080.
  • Yong, W., Lomakin, A., Kirkitadze, M.D., Teplow, D.B., Chen, S.H., and Benedek, G.B. 2002. Structure determination of micelle-like intermediates in amyloid β-protein fibril assembly by using small angle neutron scattering. Proc. Natl. Acad. Sci. 99: 150154.